Citigroup
BHVN icon

Citigroup’s Biohaven BHVN Stock Holding History

Citigroup’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-50,000
Closed -$1.2M – 5653
2025
Q1 		$1.2M Buy
+50,000
New +$1.76M ﹤0.01% 3119

Other funds holding BHVN

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $801M AUM 8.83% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
RPSM
Royalty Pharma Sub-Manager New York $173M AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citigroup's BHVN Position: Q1 2026 in Review

Citigroup increased its Biohaven (BHVN) stake by 21% in Q1 2026, buying an estimated $66.9K and bringing the position to 35,237 shares worth $298K. The position accounts for ﹤0.01% of the portfolio, ranked #3802.

Citigroup first reported a position in BHVN in Q3 2022 and has held it in 15 quarters since. The position peaked at $9.05M in Q1 2024. 275 funds tracked by Wall St. Rank hold BHVN as of Q1 2026.

  • Citigroup held 35,237 shares of Biohaven worth $298K as of Q1 2026.
  • Citigroup bought 6,112 Biohaven shares in Q1 2026, an estimated $66.9K.
  • Biohaven made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #3802 holding.
  • Citigroup first reported a position in Biohaven in Q3 2022 and has held it in 15 quarters since.
  • Citigroup's Biohaven position peaked at $9.05M in Q1 2024.
  • 275 funds tracked by Wall St. Rank held Biohaven as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.